NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Tuesday that its third quarter revenues increased 47 percent year over year as the firm beat analysts' consensus estimate on the top and bottom line.

The Seattle-based developer of molecular diagnostics and genomic research tools brought in total revenues of $12.3 million for the three months ended Sept. 30, up from $8.4 million in Q3 2013 and above the average Wall Street estimate of $11.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.